Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics

Chest

Volumn 114, Issue 4, 1998, Pages 1022-1027

  Wilson, Andrew M ^a   McFarlane, Lesley C ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adrenal suppression; Asthma; Budesonide; Cortisol; Prednisolone

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; OSTEOCALCIN; PLACEBO; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; EOSINOPHIL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MALE; NEBULIZATION; ORAL DRUG ADMINISTRATION; OSTEOBLAST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031731894     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.4.1022     Document Type: Article

References (19)

1. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52(suppl 1):S1-S21
2. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: NIH Publication No. 97-4051, 1997
3. Lipworth BJ. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol 1996; 9:19-27
4. Otulana BA, Varma N, Bullock A, et al. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med 1992; 86:105-108
5. Higenbottam TW, Clark RA, Luska AR, et al. The role of nebulized budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res 1997; 5:1-10
6. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 1997; 52:55-58
7. Wilson AM, McFarlane LC, Lipworth BJ. Dose response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med 1997; 156:1274-1277
8. Toogood JH, Lefcoe NM, Haines DS, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1997; 59:298-308
9. Toogood JH, Baskerville J, Jennings BA, et al. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989; 84:688-700
10. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991; 40:77-82
11. Lipworth BJ, Seckl JR. Measures for detecting systemic bioactivity with inhaled and intra-nasal corticosteroids. Thorax 1997; 52:476-482
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
13. Clark DJ, Grove A, Cargill RI, et al. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996; 51:262-266
14. Wales D, McDowall P, Makher H, et al. Systemic effects of high dose budesonide (4 mg) taken by four inhaler systems and orally [abstract]. Thorax 1996; 51(suppl 3):A72
15. Newnham DM, Lipworth BJ. Nebulizer performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebulizer delivery system ("Ventstream"). Thorax 1994; 49:762-770
16. Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994; 106:1788-1792
17. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996; 42:697-705
18. Brown PH, Blundell G, Greening AP, et al. Screening for hypothalmo-pituitary adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med 1991; 85:511-516
19. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80:1243-1246